CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Medicine today announced that Troy Cox, chief executive officer, is
scheduled to present at the 36th Annual J.P. Morgan Healthcare
Conference on Monday, January 8, 2018 at 3:30 p.m. PST in San Francisco.
Additionally, Troy Cox will participate in a panel discussion focused on
the Food & Drug Administration and Centers for Medicare and Medicaid
Services Parallel Review process on Monday, January 8, 2018 at 5:15 p.m.
Live, listen-only webcasts of these presentations can be accessed by
visiting the investors section of the Foundation Medicine website at
investors.foundationmedicine.com. A replay of the webcasts will be
available shortly after the conclusion of the presentation and archived
on the company's website for two weeks following the presentations.
About Foundation Medicine
Foundation Medicine (NASDAQ:FMI)
is a molecular information company dedicated to a transformation in
cancer care in which treatment is informed by a deep understanding of
the genomic changes that contribute to each patient's unique cancer. The
company offers a full suite of comprehensive genomic profiling assays to
identify the molecular alterations in a patient's cancer and match them
with relevant targeted therapies, immunotherapies and clinical trials.
Foundation Medicine's molecular information platform aims to improve
day-to-day care for patients by serving the needs of clinicians,
academic researchers and drug developers to help advance the science of
molecular medicine in cancer. For more information, please visit http://www.FoundationMedicine.com
or follow Foundation Medicine on Twitter (@FoundationATCG).
Foundation Medicine® is a registered
trademark of Foundation Medicine, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180103006057/en/
Kimberly Brown, 617-418-2215
Source: Foundation Medicine
News Provided by Acquire Media